Oxct1 - OmicsDI

Show results for

Unknown (53)
Genomics (8)
Proteomics (6)
Transcriptomics (4)
Metabolomics (1)

Organisms

Andropogon gerardi (5)
Bacteria (5)
Canis lupus familiaris (5)
Clostridium perfringens (5)
Cnidaria (5)
Cricetulus griseus (5)
Eukaryota (5)
Fasciola (5)
Hepatitis B virus (5)
Human betaherpesvirus 5 (5)
Madurella mycetomatis (5)
Mesocricetus auratus (5)
Miscanthus x giganteus (5)
Mus musculus (5)
Mycobacterium tuberculosis (5)
Orthoflavivirus (5)
Panicum virgatum (5)
Platyhelminthes (5)
Pseudomonas aeruginosa AES-1R (5)
Rattus norvegicus (5)
Saccharomyces cerevisiae (5)
Schizosaccharomyces pombe (5)
Severe acute respiratory syndrome coronavirus 2 (5)
Shigella (5)
Sorghastrum nutans (5)
Streptococcus dysgalactiae subsp. equisimilis SK1249 (5)
Streptococcus pneumoniae (5)
Homo sapiens (3)
Mus musculus (2)
Rattus norvegicus (1)

Organisms

Mus musculus (4)
Homo sapiens (3)

Repository

ENA (7)
geo (5)
pride (5)
iProX (1)
MetaboLights (1)

Tissue

Cell culture (3)
Heart (1)
Skeletal muscle cell (1)

Disease

Multiple myeloma (3)

Technology Type

Mass Spectrometry (5)
Bottom-up proteomics (2)
Mass spectrometry imaging (2)
Mass spectrometry assay (1)
Data-dependent acquisition (1)
Data-independent acquisition (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse-phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)

Metabolite Name

N-(3-bromophenyl)-2-[4-(morpholin-4-ylcarbonyl)-2-oxohydroquinolyl]acetamide (1)
1,2,4-Triazin-5(2H)-one, 6-(1,1-dimethylethyl)-3-(methylthio)- (1)
2-Hydroxy-4-Methoxychalcone (1)
P-Toluenesulfonamide (1)
2-(4-methyl-6-(2-naphthyloxy)pyrimidin-2-ylthio)-1-phenylethan-1-one (1)
2-(4-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1H-pyrazol-5-yl)-4-ethyl-5-methoxyphenol (1)
3,4-dimethyl-9-phenyl-7H-furo[2,3-f]chromen-7-one (1)
12-Hydroxy-6-Epi-Albrassitriol (1)
Ethyl 2-[2-(1,3,7-trimethyl-2,6-dioxo-1,3,7-trihydropurin-8-ylthio)benzimidazo lyl]acetate (1)
[4-(difluoromethoxy)-3-ethoxyphenyl]-N-(1-methylpyrazol-3-yl)carboxamide (1)
2-{4-[(1E)-3-oxo-3-(3,4,5-trimethoxyphenyl)prop-1-enyl]phenoxy}acetamide (1)
Methyl 2-[(5,6,7-trimethoxy-3-oxohydroisobenzofuran-4-yl)methylthio]benzoate (1)
N-(2-chlorophenyl)-2-[2-oxo-4-(piperidylcarbonyl)hydroquinolyl]acetamide (1)
NA-135 (1)
1,3,6-Trihydroxy-2-(3-methylbut-2-enyl)xanthen-9-one (1)
7-(1,6-dihydroxy-3-methyl-5-(methylethyl)-8-{[(2-methylphenyl)amino]methylene} -7-oxo(2-naphthyl))-3,8-dihydroxy-6-methyl-4-(methylethyl)-1-{[(2-methylphenyl )amino]methylene}naphthalen-2-one (1)
Phenylmethyl 1-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]pyrrolidine-2-carboxylate (1)
(2Z)-2-benzoxazol-2-yl-3-(4-hydroxy-3-methoxyphenyl)-1-(4-methylphenyl)prop-2- en-1-one (1)
Pantothenic acid (Not validated) (1)
2H-benzo[3,4-d]1,3-dioxolen-5-yl-N-(4,5,6,7-tetrahydrobenzothiazol-2-yl)carbox amide (1)
1H-indole-3-carboxamide (1)
N-(3,4-dimethylphenyl)(2-iminochromen-3-yl)carboxamide (1)
(6,6-Dimethylbicyclo[3.1.1]hept-2-yl)methyl 6-O-[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)tetrahydro-2-furanyl]-beta-D-glucopyranoside (1)
2-Chloro-1-methylpyridinium iodide (1)
4-[(4-chlorophenyl)methyl]-7-hydroxy-3-phenylchromen-2-one (1)
Transcrocetinate sodium (1)
N-(1-hydroxy-3-methylbutan-2-yl)-2-((4-oxo-3-phenyl-4H-chromen-7-yl)oxy)acetamide (1)
Methyl 2-{2-methoxy-4-[(3,4,5-trimethoxyphenyl)carbonylamino]phenoxy}acetate (1)
Acetamide, N-(3-amino-4-methoxyphenyl)- (1)
Methylthiopropene (1)

First Public Date

2025 (4)
2020 (2)
2026 (1)

Release Date

2025 (10)
2021 (10)
2024 (7)
2022 (6)
2023 (4)
2019 (4)
2016 (2)
2013 (2)
2011 (2)
2026 (1)
2020 (1)
2018 (1)
2014 (1)
2012 (1)
2010 (1)

Lab affiliation

Thirty Head Street, Yaohai District, Hefei City, Anhui Province, Anhui Medical University East Campus (2)
Anhui Hefei Anhui Medical University (1)
LEAF—Linking Landscape, Environment, Agriculture and Food Research Center, Associate Laboratory TERRA, Instituto Superior de Agronomia, Universidade de Lisboa, Tapada da Ajuda, 1349-017 Lisboa, Portugal (1)
TEDA International Cardiovascular Hospital (1)

Publication date

2026 (5)
2025 (3)
2020 (2)
2021 (1)
2024 (1)

Previous page
1 / 8
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 8
Next page

Sort by:

Relevance

Page size

Frataxin controls ketone body metabolism through regulation of OXCT1.

Not available

S-EPMC9396447 | biostudies-literature

OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma.

Not available

S-EPMC8602561 | biostudies-literature

Novel LncRNA OXCT1-AS1 indicates poor prognosis and contributes to tumorigenesis by regulating miR-195/CDC25A axis in glioblastoma.

Not available

S-EPMC8028723 | biostudies-literature

Low expression of OXCT1 promote colorectal cancer liver metastasis by upregulating CDK8 and β-catenin via H3 acetylation.

Not available

S-EPMC12765264 | biostudies-literature

Propionylation at OXCT1 lysine-296 is the key mechanism of atrial fibrillation in both patients and atrial-specific knockout of the LKB1 mouse model

Atrial fibrillation (AF), the most prevalent clinical arrhythmia, imposes a major global health burden through elevated risks of stroke, heart failure, and mortality. Lysine propionylation (Kpr) is mainly involved in metabolic regulation and plays an important role in cardiac pathophysiology. Howeve...

ORGANISM(S): Homo sapiens (Human) Mus musculus (Mouse)

2026-08-07 | PXD067998 | Pride

Mus musculus

Single cell analysis of the tumor microenvironment in OXCT1-deficient-macrophages hepatocellular carcinoma mice (PRJCA018005)

PRJDB36177 | ENA

A Rare Cause of Life-Threatening Ketoacidosis: Novel Compound Heterozygous OXCT1 Mutations Causing Succinyl-CoA:3-Ketoacid CoA Transferase Deficiency.

Not available

S-EPMC6391521 | biostudies-literature

A case of severe acidosis in a 12-month-old: Succinyl-CoA:3-ketoacid-CoA transferase deficiency with OXCT1 gene mutations.

Not available

S-EPMC9280792 | biostudies-literature

Targeting Ketone Body Metabolism in Mitigating Gemcitabine Resistance

Chemotherapy is often combined with surgery for muscle invasive and non-muscle invasive bladder cancer. However, 70% of the patients recur within 5 years. Metabolic reprogramming is an emerging hallmark in cancer chemoresistance. Here, we report a gemcitabine resistance mechanism which promotes canc...

ORGANISM(S): Homo sapiens

2025-01-02 | GSE280095 | GEO

Targeting ketone body metabolism in mitigating gemcitabine resistance.

Not available

S-EPMC11665555 | biostudies-literature

Previous page
1 / 8
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 8
Next page

Sort by:

Relevance

Page size

72 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Metabolite Name

First Public Date

Release Date

Lab affiliation

Publication date

OmicsDI is part of the ELIXIR infrastructure

Tweets